What Doses of Mounjaro Are on Backorder: Latest Supply Updates

Introduction

Walking into a pharmacy only to be told your medication is unavailable is a deeply frustrating experience. For many individuals managing metabolic health or weight loss, this has become a common hurdle. You might have found yourself calling multiple locations or waiting weeks for a refill notification that never arrives. The demand for medications like Mounjaro® has surged, leading to significant supply chain challenges and leaving many patients wondering which doses are currently on backorder.

At TrimRx, we understand the anxiety that comes with treatment interruptions. Our goal is to provide clarity on the current state of medication availability and help you navigate the complexities of modern weight management. This article covers the latest status of tirzepatide supply, which specific doses have historically faced the most pressure, and how you can manage your treatment during a shortage. By looking at the clinical landscape and the regulatory updates from the FDA, we aim to equip you with the information needed to stay on track with your health goals.

The Evolution of Mounjaro Supply Challenges

The story of the Mounjaro® shortage is largely a story of unprecedented demand. When this medication was first released, it introduced a dual-action mechanism that the market had not seen before. It is known as a GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. In plain English, a receptor agonist is a drug that mimics naturally occurring hormones in your body to trigger specific biological responses. If you want a deeper explanation of how these medications work, our guide on how GLP-1 actually works for weight loss is a helpful next read.

By mimicking both GIP and GLP-1, the medication helps the body release insulin more effectively, reduces the amount of sugar the liver produces, and significantly slows down digestion. This slowing of the “gastric emptying” process is what helps many people feel fuller for longer. Because these effects are so potent, the medication gained massive popularity, quickly outstripping the manufacturer’s ability to produce enough pens to keep up with prescriptions.

Quick Answer: As of late 2024 and early 2025, the FDA has officially removed tirzepatide (the active ingredient in Mounjaro) from the active shortage list, declaring the supply “resolved.” However, individual pharmacies may still experience local “backorders” or shipping delays for specific doses as the supply chain stabilizes.

Which Doses of Mounjaro Were on Backorder?

While the official FDA status is now “resolved,” it is helpful to look at which doses have historically been the hardest to find. Understanding this history helps explain why your local pharmacy might still have trouble keeping certain strengths on the shelf. For readers who want more context on tirzepatide access and the prescription process, how to get tirzepatide for weight loss breaks down the steps in a practical way.

Historically, the mid-to-high doses faced the most significant backorders. The medication is typically started at a low “loading dose” and gradually increased every four weeks. This process, called titration, helps the body adjust to the medication and minimizes side effects like nausea.

The Loading Doses (2.5 mg and 5 mg)

The 2.5 mg and 5 mg doses are the entry points for most patients. Because these are introductory doses intended for short-term use (usually one month each), the manufacturer often prioritized their production to ensure new patients could start their journey. Throughout the height of the shortage, these doses were generally more available than the higher strengths.

The Maintenance Doses (7.5 mg, 10 mg, and 12.5 mg)

These mid-range strengths were the most frequently reported as being on backorder. As thousands of patients moved up the titration schedule simultaneously, the demand for these “maintenance” doses skyrocketed. Many people found themselves “stuck” at a 5 mg dose because the 7.5 mg or 10 mg pens were simply not available in their region.

The Maximum Dose (15 mg)

The highest available strength also saw frequent periods of limited availability. Patients who had worked their way up to the maximum dose were often forced to drop back down to a lower available dose, which could sometimes slow their progress.

Key Takeaway: While the FDA considers the national shortage resolved, the supply chain remains sensitive. Localized “pockets” of unavailability can still occur, particularly for the 10 mg and 12.5 mg strengths.

Understanding the FDA “Resolved” Status

In October 2024, the FDA issued a significant update stating that the shortage of tirzepatide injection products had been resolved. This was followed by a subsequent declaratory order in December 2024. For a medication to be removed from the shortage list, the manufacturer must demonstrate that they have enough current and projected supply to meet the national demand.

However, “resolved” at a federal level does not always mean “available” at your corner pharmacy. There is often a lag time between the manufacturer shipping more product and that product arriving at every retail location across the country. If you are trying to understand the broader GLP-1 landscape, how semaglutide works for weight loss can also help explain why similar medications are often discussed together.

Why you might still see a backorder locally:

• Wholesaler delays: Your pharmacy’s specific supplier may have a backlog of orders to fill.
• Increased local demand: Some areas have a higher density of prescriptions, causing local stock to deplete faster than the national average.
• Pharmacy ordering cycles: Smaller pharmacies may only order stock once or twice a week, leading to temporary gaps in availability.

The Role of Compounded Tirzepatide During Shortages

One of the most common ways patients navigated the Mounjaro® shortage was through compounded medications. When a drug is on the official FDA shortage list, certain regulations allow licensed compounding pharmacies to prepare “essentially a copy” of the medication to ensure patients do not lose access to vital care.

It is critical to understand that compounded tirzepatide is not FDA-approved. While the branded versions like Mounjaro® and Zepbound® have gone through the rigorous FDA approval process for safety and efficacy, compounded versions are prepared by individual pharmacies.

At TrimRx, we prioritize your safety by connecting patients with licensed providers who can prescribe compounded medications from FDA-registered and inspected compounding pharmacies. These pharmacies must adhere to strict quality standards, but the medications themselves do not carry the same FDA-approved label as the branded pens.

The Impact of the Resolved Shortage on Compounding

Now that the FDA has declared the shortage resolved, the legal window for compounding tirzepatide is narrowing. Under federal law, pharmacies generally cannot compound medications that are “essentially copies” of commercially available drugs unless there is a shortage. If you are navigating treatment changes during this transition, the free assessment quiz can help you see whether a personalized program is a fit.

The FDA has provided a transition period for compounding pharmacies to wind down their production. For most state-licensed pharmacies, this deadline is currently set for February 2024, though ongoing legal challenges from the Outsourcing Facilities Association (OFA) have made the exact timeline a moving target.

Note: If you are currently using a compounded version of tirzepatide, it is important to speak with your provider about transitioning back to a branded version or exploring other available options as the regulatory landscape shifts.

What to Do If Your Dose Is on Backorder

If you encounter a local backorder, you do not have to wait in silence. There are several proactive steps you can take to ensure your treatment continues with as little disruption as possible.

1. Call Multiple Pharmacies

Don’t rely solely on your primary pharmacy. Different chains (and independent pharmacies) use different wholesalers. A grocery store pharmacy five miles away might have a box of your dose in stock even if the major retail chain across the street is out.

2. Request a 90-Day Supply

If your insurance allows it, ask your doctor for a 90-day prescription. When stock does arrive, getting three months at once can buffer you against future short-term supply dips. Be aware, however, that during periods of very low stock, some pharmacists may only be allowed to dispense one month at a time to ensure more patients get a dose.

3. Discuss “Dose Splitting” or Doubling with Your Doctor

If your prescribed dose is 10 mg and the pharmacy only has 5 mg in stock, your doctor might authorize you to take two 5 mg pens. Conversely, if only higher doses are available, they may have specific clinical advice. Never attempt to alter your dosage or use pens in a way not prescribed without direct medical supervision.

4. Check for Alternative Medications

Mounjaro® is part of a larger family of medications. If tirzepatide is completely unavailable in your area, your provider might suggest switching to a semaglutide-based medication like Ozempic® or Wegovy®. While they are different molecules, they work on similar pathways and can often serve as an effective bridge.

Navigating the Transition: Branded vs. Compounded

As we move out of the official shortage, many patients are transitioning from compounded tirzepatide back to branded Mounjaro® or Zepbound®. This transition should be handled carefully under medical guidance.

Differences in Administration:

• Branded Pens: These are typically single-use, pre-filled “auto-injectors.” You simply press the pen against your skin and click a button. The needle is hidden, and the dose is pre-measured.
• Compounded Vials: Compounded medication often comes in a multi-dose glass vial. You must use a traditional syringe to draw up the exact amount of liquid prescribed and self-inject.

If you are moving from a vial back to a pen, the dose remains the same, but the delivery method changes. Our team at TrimRx provides comprehensive support to help you feel comfortable with whichever delivery method your treatment plan requires.

How TrimRx Supports Your Journey

We believe that weight loss should be a personalized, stress-free experience. The world of GLP-1 medications is changing rapidly, and having a dedicated team to guide you through shortages, insurance hurdles, and dosage changes is invaluable.

Our platform simplifies the process. We start with a free assessment quiz that evaluates your health history, goals, and current needs. From there, we connect you with a licensed healthcare provider who can determine if a GLP-1 program is right for you. If you are ready to move forward, take the free assessment quiz to get started.

Our personalized approach includes:

• Telehealth Consultations: No waiting rooms or inconvenient appointments. Everything is handled online.
• Medication Access: We help you navigate the availability of both branded and compounded options (where legal and appropriate).
• Consistent Pricing: We believe in transparency, with no hidden fees, regardless of your dosage level.
• Specialist Support: Access to a team that understands the nuances of metabolic health 24/7.

Managing Side Effects During Dosing Changes

Shortages often lead to “gaps” in treatment. If you miss your dose for more than two weeks due to a backorder, your body’s tolerance to the medication may decrease. Re-starting at a high dose after a long break can lead to significant gastrointestinal side effects like nausea, vomiting, or diarrhea.

If you have experienced a lapse in your Mounjaro® supply, consult your provider before taking your next dose. They may recommend dropping back down to a lower “loading dose” for a few weeks to allow your system to re-adjust.

To support your body during these transitions, we often recommend supplemental support. Our GLP-1 Daily Support supplement is designed to provide the essential nutrients your body needs while on these medications, helping to maintain energy and digestive comfort even when your dosing schedule is disrupted.

The Future of Tirzepatide Availability

The long-term outlook for Mounjaro® and Zepbound® availability is positive. Eli Lilly has invested billions of dollars into expanding its manufacturing footprint. New facilities in North Carolina and Germany are coming online to specifically handle the production of these injectable pens.

Furthermore, as new competitors enter the market and more oral versions of these medications undergo clinical trials, the strain on the “injectable supply chain” is expected to ease. For now, the “resolved” status from the FDA is a major milestone, signaling that the most severe days of the national shortage are likely behind us.

Key Takeaway: The end of a national shortage is the beginning of a stabilization period. Stay in close contact with your provider and pharmacy as the market adjusts to the new supply levels.

How to Get Started with a Personalized Program

If you are tired of the “pharmacy hunt” or are looking for a more supported way to manage your weight, taking the first step is simple. At TrimRx, our process is designed to be as clear and supportive as possible. You can also read more about the process in how to get tirzepatide for weight loss.

Step-by-Step Onboarding:

• Step 1: Complete the Quiz. Answer a few questions about your health history and weight loss goals. This helps our providers understand your unique profile.
• Step 2: Provider Review. A licensed healthcare professional reviews your information to determine your eligibility for a GLP-1 medication.
• Step 3: Personalized Treatment Plan. If eligible, you’ll receive a treatment plan tailored to your needs, which may include branded or compounded medications.
• Step 4: Discrete Delivery. Your medication is shipped directly from a licensed pharmacy to your door, eliminating the need for frequent pharmacy visits.
• Step 5: Ongoing Support. You have 24/7 access to our team to ask questions about side effects, dosing, or supply updates.

Conclusion

While the question of “what doses of Mounjaro are on backorder” finally has a more positive answer than it did a year ago, the journey toward sustainable weight loss is rarely a straight line. The resolution of the national shortage is a win for patients everywhere, but local availability and regulatory shifts around compounding mean that staying informed is as important as ever.

Our mission at TrimRx is to remove the barriers between you and your health goals. We combine clinical expertise with an empathetic, telehealth-first approach to ensure you never feel alone in your journey. Whether you are navigating a temporary backorder or starting your very first dose, we are here to provide the science-backed guidance you deserve.

Your next step toward a healthier lifestyle is just a few clicks away. We invite you to take our free assessment quiz today to see how a personalized, medically supervised program can help you achieve lasting results.

FAQ

Is Mounjaro still on the FDA shortage list?

No, as of late 2024, the FDA has officially moved all doses of tirzepatide (Mounjaro and Zepbound) to the “resolved” list. This means the manufacturer has demonstrated the capacity to meet current national demand, though local pharmacies may still experience short-term delays in receiving stock.

Can I still get compounded tirzepatide now that the shortage is over?

While the official shortage has ended, there is a “transition period” allowing pharmacies to finish current supplies. However, the legal ability for pharmacies to compound “copies” of Mounjaro is expected to end in early 2025, pending the outcome of ongoing legal challenges.

What should I do if my local pharmacy says Mounjaro is on backorder?

If you face a local delay, try calling other pharmacies in your area, including those in different hospital systems or grocery chains. You should also contact your healthcare provider to discuss a temporary bridge, such as a different dose or a similar medication like Wegovy®, until your specific strength is back in stock. If you want help determining whether a GLP-1 program is appropriate, you can always complete the free assessment quiz.

Will I have more side effects if I switch doses due to a shortage?

Switching doses or restarting after a gap can increase the risk of gastrointestinal side effects. If you have been off the medication for more than 14 days, your provider will likely recommend restarting at a lower dose to allow your body to re-acclimatize and prevent severe nausea or discomfort.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.